USA Financial Formulas’s Organon & Co OGN Stock Holding History

USA Financial Formulas’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2	Closed	–	–	452
2021 Q4	$0	Hold	2	–	–	﹤0.01%	466
2021 Q3	$0	Hold	2	–	–	﹤0.01%	451
2021 Q2	$0	Buy	+2	New	+$66	﹤0.01%	425

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

USA Financial Formulas's OGN Position: Q1 2022 in Review

USA Financial Formulas sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 2 shares.

USA Financial Formulas first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $0 in Q4 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

USA Financial Formulas reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
USA Financial Formulas sold 2 Organon & Co shares in Q1 2022.
USA Financial Formulas first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
USA Financial Formulas's Organon & Co position peaked at $0 in Q4 2021.
818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on USA Financial Formulas's 13F filing for Q1 2022, filed 16 Aug 2022.